FDPS anticorps
-
- Antigène Voir toutes FDPS Anticorps
- FDPS (Farnesyl Diphosphate Synthase (FDPS))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp FDPS est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunofluorescence (IF)
- Réactivité croisée
- Humain, Souris, Rat
- Attributs du produit
-
Rabbit Polyclonal antibody to FDPS (farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase))
FDPS antibody [N1C3] - Purification
- Purified by antigen-affinity chromatography.
- Immunogène
- Recombinant protein encompassing a sequence within the center region of human FDPS. The exact sequence is proprietary.
- Isotype
- IgG
-
-
- Indications d'application
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: Mouse brain , rat liver
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.75 mg/mL
- Buffer
- 1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Antigène
- FDPS (Farnesyl Diphosphate Synthase (FDPS))
- Autre désignation
- farnesyl diphosphate synthase (FDPS Produits)
- Synonymes
- anticorps CG12389, anticorps DmFPPS, anticorps DmFPPSase, anticorps DmFPS, anticorps Dmel\\CG12389, anticorps FPS, anticorps fpps, anticorps fps, anticorps l(2)k06103, anticorps v(2)k03514, anticorps NCU01175.1, anticorps 16.m00760, anticorps DDBDRAFT_0206220, anticorps DDBDRAFT_0215017, anticorps DDB_0206220, anticorps DDB_0215017, anticorps FPPS, anticorps Ac2-125, anticorps (2E, anticorps 6030492I17Rik, anticorps AI256750, anticorps Fdpsl1, anticorps mKIAA1293, anticorps Farnesyl pyrophosphate synthase, anticorps farnesyl diphosphate synthase, anticorps farnesyl diphosphate synthase L homeolog, anticorps farnesyl pyrophosphate synthase, anticorps farnesyl pyrophosphate synthetase, anticorps farnesyl-pyrophosphate synthetase, anticorps FDP synthase, anticorps Farnesyl pyrophosphate synthetase, anticorps farnesyl diphosphate synthetase, anticorps farnesyl pyrophosphate synthase 1, anticorps Fpps, anticorps fdps, anticorps fdps.L, anticorps MGG_08649, anticorps TP03_0857, anticorps Tb09.160.4300, anticorps fpp, anticorps BBOV_I000120, anticorps fps, anticorps fpps, anticorps FDPS, anticorps Fdps, anticorps fps1
- Sujet
-
This gene encodes an enzyme that catalyzes the production of geranyl pyrophosphate and farnesyl pyrophosphate from isopentenyl pyrophosphate and dimethylallyl pyrophosphate. The resulting product, farnesyl pyrophosphate, is a key intermediate in cholesterol and sterol biosynthesis, a substrate for protein farnesylation and geranylgeranylation, and a ligand or agonist for certain hormone receptors and growth receptors. Drugs that inhibit this enzyme prevent the post-translational modifications of small GTPases and have been used to treat diseases related to bone resorption. Multiple pseudogenes have been found on chromosomes 1, 7, 14, 15, 21 and X. Multiple transcript variants encoding different isoforms have been found for this gene.
Cellular Localization: Cytoplasm - Poids moléculaire
- 48 kDa
- ID gène
- 2224
- UniProt
- P14324
- Pathways
- Regulation of Muscle Cell Differentiation
-